Evelo biosciences stock forecast

Author: rpsn

August undefined, 2024

WebLate-Breaking Oral Abstract, 2024 American Academy of Dermatology (AAD) Annual Meeting - March 2024. A phase 2 study investigating the effect of EDP1815, an orally-delivered, anti-inflammatory, gut-restricted commensal microbe in the treatment of mild and moderate plaque psoriasis WebThe 3 Wall Street analysts offering Evelo Biosciences stock forecast in the last 6 months have average price target of $2.33 with a high forecast of $2.5 and a low forecast of $2.0. The average Evelo Biosciences stock forecast represents a 832.0% increase from the last price of $0.25. From AI system, total return is 2366.52% from 4098 forecasts.

EVLO : Evelo Biosciences stock forecast 2024 - 2025 - 2030 - AI …

WebBased on short-term price targets offered by four analysts, the average price target for Evelo Biosciences, Inc. comes to $2.45. The forecasts range from a low of $0.30 to a … WebApr 12, 2024 · The stock’s price range for this time frame has been between $0.17 and $3.33. The trading volume of the company’s shares in Healthcare reached around 2.46 million for the day, which was evidently higher than the average daily volume of 0.23 million over the last three months. Evelo Biosciences Inc. (EVLO) has a current stock price of … glaze on dishes after dishwasher

EVLO stock forecast for 2024 – 2027 - FORECST.COM

Web2 days ago · Evelo Biosciences - EVLO - Stock Price Today - Zacks Evelo Biosciences (EVLO) (Delayed Data from NSDQ) $0.26 USD -0.04 (-13.44%) Updated Mar 17, 2024 04:00 PM ET After-Market: $0.28 +0.02... WebOn average, Wall Street analysts predict. that Evelo Biosciences's share price could reach $2.25 by Feb 15, 2024. What is EVLO's forecast return on assets (ROA) for 2024-2026? … WebFind the latest Evelo Biosciences, Inc. EVLO analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. ... EVLO Evelo … glaze or gloss for hair

Evelo Biosciences Stock Forecast - Simple Moving Average EVLO

Evelo Biosciences (EVLO) Stock Price & Analysis - TipRanks

WebFounded. 2014. Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. WebApr 6, 2024 · Stock Price Forecast. According to 12 stock analysts, the average 12-month stock price forecast for EVLO stock is $ 4.41 , which predicts an increase of 447.76%. … glaze on painted furnitureWebApr 12, 2024 · Evelo Biosciences Inc. (NASDAQ:EVLO)’s beta value is currently sitting at 1.25, while the Average True Range indicator is currently displaying 0.05. With analysts … glaze on a kitchen cabinet

"WebApr 12, 2024 · Evelo Biosciences Inc. (NASDAQ:EVLO)’s beta value is currently sitting at 1.25, while the Average True Range indicator is currently displaying 0.05. With analysts defining $0.10-$2.00 as the low and high price targets, we arrive at a consensus price target of $1.03 for the trailing 12-month period. " - Evelo biosciences stock forecast

Evelo biosciences stock forecast

Evelo Biosciences, Inc. (EVLO) Stock Price, News, Quote & History ...

WebFeb 20, 2024 · Evelo Biosciences Inc., which has a market valuation of $95.13 million, is expected to release its quarterly earnings report Mar 22, 2024 – Mar 27, 2024. Analysts tracking EVLO have forecast the quarterly EPS to shrink by -0.28 per share this quarter, while the same analysts predict the annual EPS to hit -$1.39 for the year 2024 and up to … WebThe 3 Wall Street analysts offering Evelo Biosciences stock forecast in the last 6 months have average price target of $2.33 with a high forecast of $2.5 and a low forecast of …

Did you know?

WebApr 1, 2024 · Evelo Biosciences, Inc. (EVLO) share price prediction for 2024, 2024, 2025, 2026 and 2027. EVLO one year forecast. Evelo Biosciences stock monthly and weekly … WebStock Price Forecast. The 3 analysts offering 12-month price forecasts for Evelo Biosciences Inc have a median target of 1.00, with a high estimate of 2.00 and a low …

WebApr 5, 2024 · 4 brokerages have issued 12 month price objectives for Evelo Biosciences' shares. Their EVLO share price forecasts range from $2.00 to $5.00. On average, they expect the company's share price to reach $3.17 in the next year. This suggests a … According to the issued ratings of 4 analysts in the last year, the consensus rating for … According to the Securities & Exchange Commission (SEC) insider trading … What is Concert Pharmaceuticals' stock price forecast for 2024? 4 equities … Stock Ideas and Recommendations. Get daily stock ideas from top-performing … Of the 21 institutional investors that sold Evelo Biosciences stock in the last 24 … View the latest news, buy/sell ratings, SEC filings and insider transactions for your … 4 brokers have issued twelve-month price objectives for Xeris Biopharma's stock. … WebApr 10, 2024 · A high-level overview of Evelo Biosciences, Inc. (EVLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

WebOct 22, 2024 · Evelo Biosciences Market Cap: 237.58M, Enterprise value: N/A, P/E: -1.35, PEG ratio: 0.04, EPS: -2.13, Revenue: N/A, EBITDA: -116.01M, Income: -122.80M, Profit margin: 0% WebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Evelo Biosciences (EVLO)

WebMar 16, 2024 · Evelo is a clinical-stage biotech with a vision to dramatically improve healthcare. Our work aims to harness SINTAX to modulate the body’s immune system.

WebEvelo Biosciences, Inc. (EVLO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 0.2066 +0.0216 (+11.68%) As of 11:49AM EDT. Market open. 1d. glaze on stainless chimney linerWebSep 1, 2024 · Evelo Biosciences Inc - EVLO stock news - Page 2. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public. ... Evelo Biosciences is a clinical stage biotechnology company developing orally delivered … glaze over brown paintWebEvelo Biosciences has raised a total of $326.5M in funding over 6 rounds. Their latest funding was raised on Dec 16, 2024 from a Post-IPO Debt round. Evelo Biosciences is registered under the ticker NASDAQ:EVLO . Their stock opened with $16.00 in its May 9, 2024 IPO. Evelo Biosciences is funded by 7 investors. glaze on porcelain tileWebEvelo Biosciences, Inc. (EVLO) Q4 2024 Earnings Call Transcript 03/16/23-10:28AM EST Seeking Alpha Evelo Biosciences downgraded to Neutral from Overweight at Cantor … glaze over painted kitchen cabinetsWebEvelo Biosciences price target lowered to $5 from $10 at BMO Capital March 17, 2024TipRanks Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Evelo Biosciences... body fat testing bostonWebEvelo Biosciences's earnings is forecast to decline at an annual rate of 7.5% and its revenue is expected to decline at 72.4% annually. EPS and ROE are forecast to grow 23.9% and -79.8% each year respectively. bodyfat testing appWebAug 23, 2024 · Insiders who bought Evelo Biosciences, Inc. (NASDAQ:EVLO) stock lover the last 12 months are probably not as affected by last week’s 20% loss. After accounting for the recent loss, the... glaze paint for ceramics